In-Stent RestenosisKIM, Michael S; DEAN, Larry S.Cardiovascular therapeutics (Print). 2011, Vol 29, Num 3, pp 190-198, issn 1755-5914, 9 p.Article

How many grails do we need?HOLMES, David R.Circulation (New York, N.Y.). 2004, Vol 109, Num 18, pp 2158-2159, issn 0009-7322, 2 p.Article

Preclinical restenosis models : Challenges and successesTOUCHARD, Arturo G; SCHWARTZ, Robert S.Toxicologic pathology. 2006, Vol 34, Num 1, pp 11-18, issn 0192-6233, 8 p.Conference Paper

Pushing drug-eluting stents into uncharted territory : Simpler than you think-More complex than you imagineROGERS, Campbell; EDELMAN, Elazer R.Circulation (New York, N.Y.). 2006, Vol 113, Num 19, pp 2262-2265, issn 0009-7322, 4 p.Article

Reno, a european postmarket surveillance registry, confirms effectiveness of coronary brachytherapy in routine clinical practiceCOEN, V; SERRUYS, P; SAUERWEIN, W et al.International journal of radiation oncology, biology, physics. 2003, Vol 55, Num 4, pp 1019-1026, issn 0360-3016, 8 p.Article

Do Statins have a Role in Reduction/Prevention of Post-PCI Restenosis?PRASAD, Kailash.Cardiovascular therapeutics (Print). 2013, Vol 31, Num 1, pp 12-26, issn 1755-5914, 15 p.Article

Mechanisms of post-intervention arterial remodellingGOEL, Shakti A; GUO, Lian-Wang; BO LIU et al.Cardiovascular research. 2012, Vol 96, Num 3, pp 363-371, issn 0008-6363, 9 p.Article

A classification of bifurcation restenosisSGUEGLIA, Gregory A; TODARO, Daniel; CONTE, Micaela et al.International journal of cardiology. 2011, Vol 152, Num 3, pp 385-386, issn 0167-5273, 2 p.Article

New frontiers in interventional cardiologySOUSA, J. Eduardo; COSTA, Marco A; MURAT TUZCU, E et al.Circulation (New York, N.Y.). 2005, Vol 111, Num 5, pp 671-681, issn 0009-7322, 11 p.Article

Preclinical evaluation of drug-eluting stents for peripheral applications: Recommendations from an expert consensus groupSCHWARTZ, Robert S; EDELMAN, Elazer R; GOODE, Jennifer L et al.Circulation (New York, N.Y.). 2004, Vol 110, Num 16, pp 2498-2505, issn 0009-7322, 8 p.Article

Impact of blood circulation on reendothelialization, restenosis and atrovastatin's restenosis prevention effectsSUN, Zhi-Shan; ZHOU, Sheng-Hua; XUAN GUAN et al.International journal of cardiology. 2008, Vol 128, Num 2, pp 261-268, issn 0167-5273, 8 p.Article

Current Status of Drug-Eluting StentsRABER, Lorenz; WINDECKER, Stephan.Cardiovascular therapeutics (Print). 2011, Vol 29, Num 3, pp 176-189, issn 1755-5914, 14 p.Article

Role of endogenous fas (CD95/Apo-1) ligand in balloon-induced apoptosis, inflammation, and neointima formationMATTER, Christian M; CHADJICHRISTOS, Christos E; KWAK, Brenda R et al.Circulation (New York, N.Y.). 2006, Vol 113, Num 15, pp 1879-1887, issn 0009-7322, 9 p.Article

Strut position, blood flow, and drug deposition : Implications for single and overlapping drug-eluting stentsBALAKRISHNAN, Brinda; TZAFRIRI, Abraham R; SEIFERT, Philip et al.Circulation (New York, N.Y.). 2005, Vol 111, Num 22, pp 2958-2965, issn 0009-7322, 8 p.Article

Contribution of stent underexpansion to recurrence after sirolimus-eluting stent implantation for in-stent restenosisFUJII, Kenichi; MINTZ, Gary S; REYES, Arlene et al.Circulation (New York, N.Y.). 2004, Vol 109, Num 9, pp 1085-1088, issn 0009-7322, 4 p.Article

Molecular basis of restenosis and drug-eluting stentsCOSTA, Marco A; SIMON, Daniel I.Circulation (New York, N.Y.). 2005, Vol 111, Num 17, pp 2257-2273, issn 0009-7322, 17 p.Article

Bringing reality to drug-eluting stentsFAXON, David P.Circulation (New York, N.Y.). 2004, Vol 109, Num 2, pp 140-142, issn 0009-7322, 3 p.Article

Five-year follow-up after intracoronary gamma Radiation therapy for in-stent restenosisWAKSMAN, Ron; AJANI, Andrew E; PINNOW, Ellen et al.Circulation (New York, N.Y.). 2004, Vol 109, Num 3, pp 340-344, issn 0009-7322, 5 p.Article

Nanospheres of a bisphosphonate attenuate intimal hyperplasiaCOHEN-SELA, Einat; DANGOOR, David; EPSTEIN, Hila et al.Journal of nanoscience and nanotechnology (Print). 2006, Vol 6, Num 9-10, pp 3226-3234, issn 1533-4880, 9 p.Article

Drug-eluting stent technologies for vascular regenerationSCHMITZ, Klaus-Peter; GRABOW, Niels; LOBLER, Marian et al.International journal of materials research. 2007, Vol 98, Num 7, pp 637-642, issn 1862-5282, 6 p.Article

Esculetin inhibits Ras-mediated cell proliferation and attenuates vascular restenosis following angioplasty in ratsPAN, Shiow-Lin; HUANG, Ying-Wen; GUH, Jih-Hwa et al.Biochemical pharmacology. 2003, Vol 65, Num 11, pp 1897-1905, issn 0006-2952, 9 p.Article

A novel experimental method to estimate stress-strain behavior of intact coronary arteries using intravascular ultrasound (IVUS)TAJADDINI, Azita; KILPATRICK, Deborah L; VINCE, D. Geoffrey et al.Journal of biomechanical engineering. 2003, Vol 125, Num 1, pp 120-123, issn 0148-0731, 4 p.Article

Vascular brachytherapy using a beta emitter source in diabetic patients with in-stent restenosis: Angiographic and clinical outcomesSUNTHARALINGAM, Mohan; LASKEY, Warren K; KUNTZ, Richard et al.International journal of radiation oncology, biology, physics. 2003, Vol 57, Num 2, pp 536-542, issn 0360-3016, 7 p.Article

Sirolimus eluting stent restenosis: Impact of angiographic patterns and the treatment factors on angiographic outcomes in contemporary practiceRATHORE, Sudhir; KINOSHITA, Yoshihisa; ASAKURA, Yasushi et al.International journal of cardiology. 2011, Vol 146, Num 3, pp 390-394, issn 0167-5273, 5 p.Article

Ramatroban, a thromboxane A₂ receptor antagonist, prevents macrophage accumulation and neointimal formation after balloon arterial injury in cholesterol-fed rabbitsISHIZUKA, Toshiaki; MATSUMURA, Kouji; MATSUI, Takemi et al.Journal of cardiovascular pharmacology. 2003, Vol 41, Num 4, pp 571-578, issn 0160-2446, 8 p.Article